Nothing Special   »   [go: up one dir, main page]

DE69521300D1 - Präparate mit lipophilen trägerstoffen - Google Patents

Präparate mit lipophilen trägerstoffen

Info

Publication number
DE69521300D1
DE69521300D1 DE69521300T DE69521300T DE69521300D1 DE 69521300 D1 DE69521300 D1 DE 69521300D1 DE 69521300 T DE69521300 T DE 69521300T DE 69521300 T DE69521300 T DE 69521300T DE 69521300 D1 DE69521300 D1 DE 69521300D1
Authority
DE
Germany
Prior art keywords
polar
pct
pharmaceutical composition
relates
polar lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69521300T
Other languages
English (en)
Other versions
DE69521300T2 (de
Inventor
Anders Carlsson
Bengt Hersloef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipocore Holding Stockholm Se AB
Original Assignee
Scotia LipidTeknik AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx
Priority claimed from SE9402456A external-priority patent/SE517678C2/sv
Application filed by Scotia LipidTeknik AB filed Critical Scotia LipidTeknik AB
Application granted granted Critical
Publication of DE69521300D1 publication Critical patent/DE69521300D1/de
Publication of DE69521300T2 publication Critical patent/DE69521300T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69521300T 1994-02-04 1995-02-06 Präparate mit lipophilen trägerstoffen Expired - Lifetime DE69521300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400368A SE9400368D0 (sv) 1994-02-04 1994-02-04 Glycolipid material
SE9402456A SE517678C2 (sv) 1994-07-12 1994-07-12 Lipofila bärarpreparat med en kontinuerlig lipidfas
PCT/SE1995/000117 WO1995020945A1 (en) 1994-02-04 1995-02-06 Lipophilic carrier preparations

Publications (2)

Publication Number Publication Date
DE69521300D1 true DE69521300D1 (de) 2001-07-19
DE69521300T2 DE69521300T2 (de) 2002-05-02

Family

ID=26661956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521300T Expired - Lifetime DE69521300T2 (de) 1994-02-04 1995-02-06 Präparate mit lipophilen trägerstoffen

Country Status (19)

Country Link
US (1) US5716639A (de)
EP (1) EP0743851B1 (de)
JP (1) JP3203359B2 (de)
KR (1) KR100220546B1 (de)
CN (1) CN1091591C (de)
AT (1) ATE201980T1 (de)
AU (1) AU691250B2 (de)
CA (1) CA2182577C (de)
DE (1) DE69521300T2 (de)
DK (1) DK0743851T3 (de)
ES (1) ES2158084T3 (de)
FI (1) FI963066A (de)
HU (1) HU221432B (de)
MY (1) MY112435A (de)
NO (1) NO312495B1 (de)
NZ (1) NZ279954A (de)
PL (1) PL178394B1 (de)
TW (1) TW482685B (de)
WO (1) WO1995020945A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
EA001326B1 (ru) * 1996-05-10 2001-02-26 Унилевер Н.В. Композиция, содержащая жидкий жирный компонент
EA001116B1 (ru) * 1996-05-10 2000-10-30 Яманоути Юроп Б.В. Быстрорастворимый везикулярный продукт
GR1002706B (el) * 1996-05-22 1997-05-26 Μικρογαλακτωματα λεκιθινης περιεχοντα πρωτεολυτικα ενζυμα α-χυμοθρυψινης η θρυψινη και μεθοδος μονιμης ενζυμικης αποτριχωσης.
DE19645657A1 (de) * 1996-11-06 1998-05-28 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
SE9702630D0 (sv) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (de) * 1999-03-30 2014-08-20 Sodic Sa Pflanzenextrakt auf Glycerid-, Phospholipid- und Phytosphingolipidbasis, Verfahren für die Gewinnung dieses Extrakts und ihn enthaltende kosmetische Zusammensetzungen
US6916488B1 (en) * 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
EP1151745A1 (de) * 2000-05-05 2001-11-07 L'oreal Wasser-in-Öl Emulsion und deren Verwendung in Kosmetika
WO2003035112A1 (fr) * 2001-10-22 2003-05-01 Jiro Kanie Nutriant enteral et procede de production de celui-ci
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7658964B2 (en) * 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
ES2258694T3 (es) 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
JP4994039B2 (ja) * 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド 脂溶性または疎水性化合物の送達に有用なミセル系
CA2593956A1 (en) 2004-12-22 2006-06-29 Lipopeptide Ab Agents inhibiting the cathelin-like protein cap18/ll-37
ATE554656T1 (de) * 2005-03-04 2012-05-15 Dsm Ip Assets Bv Teilchenförmige nahrungsmittel-lipid- zusammensetzung
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023638A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt an Glucosylglyceriden und einem oder mehreren Acrylamidomethylpropylsulfonsäure-Polymeren
EA012422B1 (ru) * 2005-09-16 2009-10-30 ДСМ АйПи АССЕТС Б.В. Фармацевтическая липидная композиция в виде частиц
PL2068825T3 (pl) 2006-10-04 2011-06-30 M & P Patent Ag Układ dostarczania o kontrolowanym uwalnianiu do donosowego podawania związków neuroprzekaźnikowych
EP2174646B1 (de) * 2007-08-09 2019-05-22 Kao Corporation Umgedrehtes vesikel
US20090137497A1 (en) * 2007-11-23 2009-05-28 Beiersdorf Ag Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
US20090285869A1 (en) * 2008-05-14 2009-11-19 Humco Holding Group, Inc. Salt stable lecithin organogel composition
JP2010104946A (ja) * 2008-10-31 2010-05-13 Riso Kagaku Corp 逆ベシクルを用いて形成された油中水（ｗ／ｏ）型エマルション
CN101787059B (zh) * 2009-05-12 2014-10-15 沈阳药科大学 双半乳糖基二酰甘油酯的制备方法及其应用
ES2548681T3 (es) * 2010-03-24 2015-10-20 Medesis Pharma Sistema micelar inverso que comprende iones metálicos y uso del mismo
NO2575768T3 (de) * 2010-05-24 2018-05-12
EP2389816A1 (de) 2010-05-25 2011-11-30 Nestec S.A. Synergistische Antioxidanszusammensetzung
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
JP6239822B2 (ja) * 2012-12-27 2017-11-29 ポーラ化成工業株式会社 逆ベシクル組成物
JP6242582B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6334151B2 (ja) * 2012-12-25 2018-05-30 ポーラ化成工業株式会社 逆ベシクル組成物
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP6242581B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
ES2669614T3 (es) * 2013-04-16 2018-05-28 Dow Global Technologies Llc Masa y pastel estratificado de bajo contenido en grasa
WO2020237383A1 (en) * 2019-05-31 2020-12-03 Groupe Santé Devonian Inc. Thylakoids as delivery system for cannabinoïds and other molecules and formulations thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (de) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposome zur Freigabe von Arzneimitteln und eine ein Arzneimittelsystem mit liposomen enthaltende Bereitung
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
JP2774429B2 (ja) * 1992-03-17 1998-07-09 株式会社ディ・ディ・エス研究所 糖骨格を有する分枝鎖型誘導体

Also Published As

Publication number Publication date
CN1140405A (zh) 1997-01-15
AU691250B2 (en) 1998-05-14
NO312495B1 (no) 2002-05-21
FI963066A (fi) 1996-09-30
HUT75470A (en) 1997-05-28
DK0743851T3 (da) 2001-09-03
DE69521300T2 (de) 2002-05-02
ES2158084T3 (es) 2001-09-01
ATE201980T1 (de) 2001-06-15
HU9602142D0 (en) 1996-09-30
CN1091591C (zh) 2002-10-02
JP3203359B2 (ja) 2001-08-27
NO963242L (no) 1996-08-02
NO963242D0 (no) 1996-08-02
FI963066A0 (fi) 1996-08-02
CA2182577A1 (en) 1995-08-10
EP0743851A1 (de) 1996-11-27
KR100220546B1 (ko) 1999-09-15
TW482685B (en) 2002-04-11
CA2182577C (en) 2002-08-20
US5716639A (en) 1998-02-10
PL315780A1 (en) 1996-12-09
WO1995020945A1 (en) 1995-08-10
MY112435A (en) 2001-06-30
AU1723595A (en) 1995-08-21
JPH09508415A (ja) 1997-08-26
HU221432B (en) 2002-10-28
PL178394B1 (pl) 2000-04-28
NZ279954A (en) 1998-02-26
EP0743851B1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
DE69521300D1 (de) Präparate mit lipophilen trägerstoffen
EE03220B1 (et) Õli-vees-emulsioon, selle kasutamine ja seda sisaldav farmatseutiline kompositsioon
MY113341A (en) Bilayer preparations
DK0680750T3 (da) Kosmetisk eller farmaceutisk sammensætning til topisk anvendelse
IT8822053A0 (it) Procedimento per la preparazione di emulsioni detergenti per cosmesie prodotti cosmetici ottenuti.
CA2032106A1 (fr) Composition cosmetique pour le soin des cheveux et utilisation de ladite composition
ATE219940T1 (de) Arzneimittel enthaltende cyclosporinderivate
ATE221369T1 (de) Emulsion enthaltend eine gelierte wässerige aüssere phase, eine nichtwässerige zwischenphase und eine wässerige innere phase
RU95102782A (ru) Косметические композиции для местного применения, вызывающие искусственный загар, способ их получения и применение
AU5178193A (en) Solubilizing agents
DE60120652D1 (de) Emulsion enthaltend siliconöl- und co-lösungsmittelsystem enhaltend fettlösliche kosmetische wirkstoffe und daraus hergestelleten kosmetischen zubereitungen
MX9603038A (es) Emulsiones de aceite en agua.
SE9402456D0 (sv) Liphophilic carrier preparations
ES1034623U (es) Dispositivo para la limpieza de frutos.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LIPOCORE HOLDING AB, STOCKHOLM, SE

8364 No opposition during term of opposition